Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

Published Date: 15 Jan 2024

A dose of 70 Gy divided into 15 fractions demonstrated a good balance between safety and effectiveness in a small trial.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

2.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

3.

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

4.

Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.

5.

The pathology of incurable cancers can be predicted thanks to research.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot